|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT02223793 |
|
Date of registration:
|
18/08/2014 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Vascular Lifestyle-Intervention and Screening in Pharmacy
VISA |
|
Scientific title:
|
Effects of Cardiovascular Risk Screening in Pharmacies: A Randomized Study |
|
Date of first enrolment:
|
September 2014 |
|
Target sample size:
|
582 |
|
Recruitment status: |
Active, not recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT02223793 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Screening. Masking: Single (Participant).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Norway
| | | | | | | |
|
Contacts
|
|
Name:
|
Karianne Svendsen, M.Sc. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Oslo |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Above18 years
- Not pregnant or lactating
- Not previous cardiovascular events nor treatment related to cardiovascular disease
((myocardial infarction, stroke, angina pectoris, coronary artery bypass, -
Percutaneous coronary intervention, diabetes type 1 and 2)
- No use of cholesterol lowering medication, bloodpressure lowering medication,
bloodsugar lowering medication or medication related to diabetes
Exclusion Criteria:
- Below18 years
- Pregnant or lactating
- Previous cardiovascular events nor treatment related to cardiovascular disease
(myocardial infarction, stroke, angina pectoris, coronary artery bypass,
- Percutaneous coronary intervention, diabetes type 1 and 2)
- Use of cholesterol lowering medication, bloodpressure lowering medication, bloodsugar
lowering medication or medication related to diabetes
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Cardiovascular Diseases
|
|
Dyslipidemia
|
|
Hypercholesterolemia
|
|
Hypertensive Disease
|
|
Diabetes Mellitus, Type 2
|
|
Intervention(s)
|
|
Behavioral: Information on high risk factor levels and lifestyle advice
|
|
Behavioral: No information on high risk factor levels but lifestyle advice
|
|
Behavioral: No information on high risk factor levels, nor lifestyle advice
|
|
Primary Outcome(s)
|
|
Change in ad Hoc Risk Score (Measure on a Scale From Min 4 to Max 14)
[Time Frame: Baseline and at 8 weeks]
|
|
Secondary Outcome(s)
|
|
8-week Change in Total Cholesterol
[Time Frame: At baseline and at 8 weeks]
|
|
Secondary ID(s)
|
|
39255 (NSD)
|
|
2013/1660
|
|
1660/2013
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|